‘We need to take risks’: Chanel gets gritty with Marseille show
Related Articles
-
Covishield, Marketed In India By Serum Institute Reported To Raise Disorder Risk
NEW DELHI, (IANS) – Thrombosis Thrombocytopenia Syndrome (TTS) — a blood clot disorder — is a rare side effect of AstraZeneca’s Covid vaccine, and the benefits far outweigh the risks of the jab, said doctors here on April 30. This comes after reports said that […]
-
AstraZeneca's admission of Covishield risk may spark legal battles in India
Pharmaceutical giant AstraZeneca has legally acknowledged for the first time that its COVID-19 vaccine, under the global brand names Covishield and Vaxzevria, could trigger a rare adverse health condition.The vaccine producer stated in court documents that the inoculation could occasionally induce Thrombosis with Thrombocytopenia Syndrome (TTS), a disorder resulting in blood clots and a reduced platelet count, as reported in The Telegraph. A class action lawsuit, on account of allegations that...
-
Nursing couple in need of financial help as daughter fights for her life in lupus battle
DOTHAN, Ala. (WDHN) — Ryan and Wendy Sansom who are nurses themselves in the community are in the hospital caring for their daughter Angelina Xiong who is fighting for her life in the ICY at UAB in Birmingham battling lupus -- an auto immune disease. "You help other people go through this but experiencing this []